{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:22:26Z","timestamp":1777699346684,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.dld.2014.12.017","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T07:32:55Z","timestamp":1421047975000},"page":"315-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats"],"prefix":"10.1016","volume":"47","author":[{"given":"Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jikai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-1757","authenticated-orcid":false,"given":"Shouli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.dld.2014.12.017_bib0185","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0168-8278(02)00430-0","article-title":"Current management of portal hypertension","volume":"38","author":"Bosch","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/liv.12360","article-title":"Beta-blockers in portal hypertension: new developments and controversies","volume":"34","author":"Tripathi","year":"2014","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2014.12.017_bib0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.27251","article-title":"VASP promotes TGF-beta activation of hepatic stellate cells by regulating Rab11 dependent plasma membrane targeting of TGF-beta receptors","volume":"61","author":"Tu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0200","doi-asserted-by":"crossref","first-page":"e64227","DOI":"10.1371\/journal.pone.0064227","article-title":"Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2014.12.017_bib0205","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"Yang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.12.017_bib0210","doi-asserted-by":"crossref","first-page":"e92273","DOI":"10.1371\/journal.pone.0092273","article-title":"Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling","volume":"9","author":"Nakamura","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dld.2014.12.017_bib0215","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","article-title":"Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells","volume":"170","author":"Novo","year":"2007","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.dld.2014.12.017_bib0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/ijo.2014.2250","article-title":"Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2\/STAT3 pathway","volume":"44","author":"Joung","year":"2014","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.dld.2014.12.017_bib0225","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","article-title":"JAK\/STAT3 signaling is required for TGF-beta-induced epithelial-mesenchymal transition in lung cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.dld.2014.12.017_bib0230","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.3390\/molecules181012809","article-title":"Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2\/STAT3 and ERK1\/2 pathway","volume":"18","author":"Wang","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.dld.2014.12.017_bib0235","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/mt.2014.102","article-title":"Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice","volume":"22","author":"Chong","year":"2014","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.dld.2014.12.017_bib0240","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3892\/ijo.2011.1261","article-title":"Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis","volume":"40","author":"Yang","year":"2012","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.dld.2014.12.017_bib0245","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10753-014-9820-6","article-title":"Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice","volume":"37","author":"Gyurkovska","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.dld.2014.12.017_bib0250","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6577","article-title":"Animal models of portal hypertension","volume":"12","author":"Abraldes","year":"2006","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.12.017_bib0255","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/hep.26520","article-title":"Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats","volume":"58","author":"Rosado","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/CH-2011-1448","article-title":"Alpha smooth muscle actin in the cycling ovary \u2013 an immunohistochemical study","volume":"50","author":"Hirschberg","year":"2012","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1016\/j.dld.2014.12.017_bib0265","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.dld.2014.12.017_bib0270","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation","volume":"288","author":"Liu","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.dld.2014.12.017_bib0275","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biocel.2012.12.019","article-title":"Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells","volume":"45","author":"Zhang","year":"2013","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.dld.2014.12.017_bib0280","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.dld.2014.12.017_bib0285","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2014.12.017_bib0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jgh.12032","article-title":"Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease","volume":"28","author":"Kong","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","volume":"60","author":"Granzow","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0300","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.dld.2014.12.017_bib0305","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis \u2013 current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0310","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jcmm.12286","article-title":"Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells","volume":"18","author":"Zhang","year":"2014","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.dld.2014.12.017_bib0315","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats","volume":"28","author":"Gupta","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0320","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0325","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.01.025","article-title":"Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats","volume":"60","author":"Schwabl","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0330","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state","volume":"290","author":"Abraldes","year":"2006","journal-title":"American Journal of Physiology \u2013 Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.dld.2014.12.017_bib0335","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hep.26995","article-title":"Disruption of negative feedback loop between vasohibin-1 and VEGF decreases portal pressure, angiogenesis and fibrosis in cirrhotic rats","volume":"60","author":"Coch","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0340","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.3748\/wjg.v19.i28.4464","article-title":"Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy","volume":"19","author":"Marques","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.12.017_bib0345","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats","volume":"51","author":"Reiberger","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.12.017_bib0350","first-page":"H1021","article-title":"iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats","volume":"300","author":"Kajita","year":"2011","journal-title":"American Journal of Physiology: Heart and Circulatory Physiology"},{"key":"10.1016\/j.dld.2014.12.017_bib0355","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00595-012-0405-4","article-title":"Warren shunt combined with partial splenectomy for children with extrahepatic portal hypertension, massive splenomegaly, and severe hypersplenism","volume":"43","author":"Sretenovic","year":"2013","journal-title":"Surgery Today"},{"key":"10.1016\/j.dld.2014.12.017_bib0360","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.01.004","article-title":"Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension","volume":"52","author":"Mejias","year":"2010","journal-title":"Journal of Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T21:37:31Z","timestamp":1598650651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S159086581500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2014.12.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2014.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}